Short leukocyte telomere length predicts risk of diabetes in american indians: the strong heart family study
- PMID: 23949319
- PMCID: PMC3868043
- DOI: 10.2337/db13-0744
Short leukocyte telomere length predicts risk of diabetes in american indians: the strong heart family study
Abstract
Telomeres play a central role in cellular aging, and shorter telomere length has been associated with age-related disorders including diabetes. However, a causal link between telomere shortening and diabetes risk has not been established. In a well-characterized longitudinal cohort of American Indians participating in the Strong Heart Family Study, we examined whether leukocyte telomere length (LTL) at baseline predicts incident diabetes independent of known diabetes risk factors. Among 2,328 participants free of diabetes at baseline, 292 subjects developed diabetes during an average 5.5 years of follow-up. Compared with subjects in the highest quartile (longest) of LTL, those in the lowest quartile (shortest) had an almost twofold increased risk of incident diabetes (hazard ratio [HR] 1.83 [95% CI 1.26-2.66]), whereas the risk for those in the second (HR 0.87 [95% CI 0.59-1.29]) and the third (HR 0.95 [95% CI 0.65-1.38]) quartiles was statistically nonsignificant. These findings suggest a nonlinear association between LTL and incident diabetes and indicate that LTL could serve as a predictive marker for diabetes development in American Indians, who suffer from disproportionately high rates of diabetes.
Figures
Comment in
-
The long and short of telomere length and diabetes.Diabetes. 2014 Jan;63(1):65-7. doi: 10.2337/db13-1469. Diabetes. 2014. PMID: 24357701 No abstract available.
References
-
- Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1965;37:614–636 - PubMed
-
- Adaikalakoteswari A, Balasubramanyam M, Mohan V. Telomere shortening occurs in Asian Indian Type 2 diabetic patients. Diabet Med 2005;22:1151–1156 - PubMed
-
- Zee RY, Castonguay AJ, Barton NS, Germer S, Martin M. Mean leukocyte telomere length shortening and type 2 diabetes mellitus: a case-control study. Transl Res 2010;155:166–169 - PubMed
Publication types
MeSH terms
Grants and funding
- R01DK091369/DK/NIDDK NIH HHS/United States
- U01 HL041642/HL/NHLBI NIH HHS/United States
- U01 HL041654/HL/NHLBI NIH HHS/United States
- K01 AG034259/AG/NIA NIH HHS/United States
- U01 HL041652/HL/NHLBI NIH HHS/United States
- U01HL41642/HL/NHLBI NIH HHS/United States
- U01HL65521/HL/NHLBI NIH HHS/United States
- R21HL092363/HL/NHLBI NIH HHS/United States
- K01AG034259/AG/NIA NIH HHS/United States
- U01 HL065521/HL/NHLBI NIH HHS/United States
- U01HL41654/HL/NHLBI NIH HHS/United States
- R01 HL109301/HL/NHLBI NIH HHS/United States
- U01 HL065520/HL/NHLBI NIH HHS/United States
- R01 DK091369/DK/NIDDK NIH HHS/United States
- U01HL41652/HL/NHLBI NIH HHS/United States
- R21 HL092363/HL/NHLBI NIH HHS/United States
- U01HL65520/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
